Wednesday, July 17, 2019
    Latest

    Harvard

    Home Harvard
    Anti-Cancer Agent E7130
    Harvard

    Harvard Breakthrough Anti-Cancer Agent E7130 Nearing Clinicals

    0
    plant based diet
    Harvard

    Harvard Research: Reduce Cardiovascular Disease by Replacing Red Meat with Plant...

    0
    Harvard

    Harvard & Rand Corp Study Evidence: Massive Opioid Prescriptions Clinical Need...

    0
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved